Skip to main content

Table 4 Surface modified decellularized vascular matrix for vascular scaffolds

From: The application of composite scaffold materials based on decellularized vascular matrix in tissue engineering: a review

Tissue source

Animal model

Modification

Patency rate

Refs.

Human placenta chorion

Rat infrarenal aorta

Heparin

100% at 1 month

[50]

Bovine jugular vein

Rat

Heparin/DHI

–

[51]

Sheep carotid artery

–

CKC

–

[53]

Rat abdominal aorta

Rat abdominal aorta

S1P

100% at 2 weeks

[55]

Rabbit abdominal aorta

Dog femoral artery

VEGF/bFGF

90% at 18 months

[58]

Rat abdominal aorta

Rat abdominal aorta

GCSF

100% at 8 weeks

[59]

Rat thoracic aorta

Rat infrarenal abdominal aorta

HG-VEGF

100% at 8 weeks

[39]

Porcine aortic valve

Rat

VEGF /PLC

–

[60]

Rat abdominal aorta

–

CBP/heparin

–

[61]

Equine carotid artery

Sheep right cervical AV fistulae

CCN1

100% at 14 weeks

[65]

Rabbit artery

Nude mice

HLC-I

–

[67]

Rat aortic conduits

Rat aortic conduit

Fibronectin

–

[68]

Rat thoracic aorta

Rat infrarenal aorta

Fibronectin/ SDF1α

100% at 8 weeks

[69]

Bovine pericardium

Nude rat abdominal aorta

PPF

100% at 2 weeks

[71]

Umbilical cord and placental artery

–

GO

–

[73]

Rat abdominal aorta

–

POC

–

[74]

Rat descending aorta

Rat abdominal aorta

PCL

100% at 6 weeks

[77]